Table 2.
Univariate and multivariate analysis of colon cancer overall survival based on the training cohort.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Log rank χ2 test | P-value | HR (95%CI) | P-value | |
| Age | 85.866 | < 0.001 | < 0.001 | |
| < 65 | reference | |||
| ≥ 65 | 1.448 (1.315-1.595) | |||
| Gender | 0.012 | 0.912 | NI | |
| Female | ||||
| Male | ||||
| Race | 3.420 | 0.181 | NI | |
| White | ||||
| Black | ||||
| Other a | ||||
| Grade | 140.085 | < 0.001 | < 0.001 | |
| I | reference | |||
| II | 0.948 (0.724-1.241) | |||
| III | 1.365 (1.037-1.796) | |||
| IV | 1.506 (1.110-2.044) | |||
| T stage | 285.727 | < 0.001 | < 0.001 | |
| T1 | reference | |||
| T2 | 1.586 (0.612-4.109) | |||
| T3 | 1.958 (0.806-4.755) | |||
| T4 | 2.972 (1.222-7.227) | |||
| N stage | 258.274 | < 0.001 | < 0.001 | |
| N0 | reference | |||
| N1 | 1.677 (1.444-4.109) | |||
| N2 | 1.733 (1.478-2.032) | |||
| M stage | 710.426 | < 0.001 | < 0.001 | |
| M0 | reference | |||
| M1 | 3.058 (2.763-3.384) | |||
| Surgery | 1.028 | 0.311 | NI | |
| No | ||||
| Yes | ||||
| Radiotherapy | 0.001 | 0.976 | NI | |
| No/unknown | ||||
| Yes | ||||
| Chemotherapy | 144.422 | < 0.001 | < 0.001 | |
| No/unknown | reference | |||
| Yes | 0.338 (0.306-0.374) | |||
| Tumor size | 97.624 | <0.001 | < 0.001 | |
| <3cm | reference | |||
| 3-5cm | 1.121 (0.956-1.315) | |||
| >5cm | 1.329 (1.133-1.559) | |||
| CEA | 207.361 | < 0.001 | < 0.001 | |
| Negative/normal | reference | |||
| Positive/elevated | 1.401 (1.268-1.548) | |||
| Insurance | 9.125 | 0.010 | 0.029 | |
| Any Medicaid | reference | |||
| Insured | 0.880 (0.778-0.995) | |||
| Uninsured | 1.090 (0.869-1.366) | |||
| Marital status | 45.317 | < 0.001 | < 0.001 | |
| Married | reference | |||
| Unmarried | 1.242 (1.136-1.359) | |||
T, Tumor; N, Node; M, Metastasis; CEA, carcinoembryonic antigen; NI, not included in the multivariate survival analysis.
other includes American Indian/AK Native, Asian/Pacific Islander and unknowns.